ResMed (RMD) News Today → $5,000 Gold? (From Stansberry Research) (Ad) Free RMD Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIs the Resmed share price a buy before the ex-dividend day?msn.com - May 2 at 1:30 AMResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcriptfinance.yahoo.com - April 30 at 3:06 PMResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Nextfinance.yahoo.com - April 30 at 7:50 AMResMed Shares Climb on Strong 3Q Resultsmarketwatch.com - April 26 at 10:42 AMKeyBanc Keeps Their Buy Rating on Resmed (RMD)markets.businessinsider.com - April 26 at 10:42 AMResMed tops quarterly profit estimates on strong demand for sleep apnea devicesreuters.com - April 26 at 12:34 AMScoPo’s Powerplays: Nowhere to hide as ASX health stocks tumble in broader selloffmsn.com - April 19 at 12:12 AMWhy is the ResMed share price diving 5% today?fool.com.au - April 17 at 11:08 PMResmed Stock Poised for Growth: Buy Rating Affirmed Amid Revenue Upswing and Margin Expansionmarkets.businessinsider.com - April 17 at 1:07 PMWarren Buffett Detailed Fundamental Analysis - RMDnasdaq.com - April 17 at 1:51 AMResMed share price target raised by RBC Capitaluk.investing.com - April 12 at 7:09 AM3 ASX 200 healthcare stocks that could deliver big returns for investorsmsn.com - April 12 at 2:09 AMMizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decreemsn.com - April 10 at 6:20 PMResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 61%finance.yahoo.com - April 1 at 3:28 PM$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Todaybenzinga.com - March 28 at 7:34 PMExpert Outlook: ResMed Through The Eyes Of 9 Analystsmarkets.businessinsider.com - March 27 at 3:10 PMResMed Inc. (RMD.AX)au.finance.yahoo.com - March 24 at 4:21 PMHere's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investorsfinance.yahoo.com - March 8 at 9:52 AMRMD Mar 2024 210.000 putfinance.yahoo.com - March 3 at 11:03 PMNotable Two Hundred Day Moving Average Cross - RMDnasdaq.com - March 1 at 8:30 AMHere's why ResMed shares can jump a further 20%fool.com.au - February 26 at 12:20 AMThese super-strong ASX 200 blue chip shares that could deliver 20% returnsfool.com.au - February 23 at 1:52 PMIs ResMed Inc.'s (NYSE:RMD) Recent Stock Performance Tethered To Its Strong Fundamentals?finance.yahoo.com - February 20 at 1:49 PMASX blue chip shares: The best of the best for February 2024fool.com.au - February 20 at 12:59 AMRMD Mar 2024 220.000 callfinance.yahoo.com - February 20 at 12:59 AMResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)finance.yahoo.com - February 16 at 1:42 PMWhat's happening with the ResMed share price on Wednesday?fool.com.au - February 6 at 8:07 PMHoping to bag the ResMed dividend? You better be quick!fool.com.au - February 5 at 12:33 PMWhy ResMed (RMD) is a Top Growth Stock for the Long-Termfinance.yahoo.com - February 5 at 12:33 PMHere's How Much You Would Have Made Owning ResMed Stock In The Last 15 Yearsbenzinga.com - February 1 at 3:50 PMOppenheimer Keeps Their Buy Rating on Resmed (RMD)markets.businessinsider.com - January 31 at 3:09 AMResMed shares rise on major Philips newsfool.com.au - January 29 at 10:57 PMThe Rally in ResMed Looks Ready to Take a Breathrealmoney.thestreet.com - January 29 at 5:56 PMResmed Stock Buy Rating Affirmed Amidst Market Opportunity and Strong Financialsmarkets.businessinsider.com - January 29 at 12:56 PMWhy it isn't too late to buy ResMed sharesfool.com.au - January 28 at 7:52 PMResMed Surges And Retakes A Key Line As The Battle With Weight-Loss Drugs Ragesfinance.yahoo.com - January 25 at 7:16 PMResmed Receives Strong Buy Rating on Robust Sales, Margin Expansion, and Promising Treatment Synergiesmarkets.businessinsider.com - January 25 at 2:16 PMWhy ResMed Stock Is Jumping Todayfinance.yahoo.com - January 25 at 2:16 PMCracking The Code: Understanding Analyst Reviews For ResMedmarkets.businessinsider.com - January 25 at 2:16 PMResMed Surges But Hits A Ceiling As The Battle With Weight-Loss Drugs Ragesfinance.yahoo.com - January 25 at 2:16 PMResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcriptfinance.yahoo.com - January 25 at 2:16 PMResMed (RMD) Q2 Earnings Beat Estimates, Margins Expandfinance.yahoo.com - January 25 at 2:16 PMResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Linefinance.yahoo.com - January 25 at 9:14 AMRecap: ResMed Q2 Earningsbenzinga.com - January 24 at 6:12 PMResmed Inc Q2 Profit Decreases, but beats estimatesmarkets.businessinsider.com - January 24 at 6:12 PMResMed shares on watch after smashing Q2 expectationsfool.com.au - January 24 at 6:12 PMResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024finance.yahoo.com - January 24 at 6:12 PMResMed Inc (RMD) Reports Solid Revenue Growth in Q2 FY2024 Amidst Expanding Global Market Presencefinance.yahoo.com - January 24 at 6:12 PMHedge fund LHC buys in ResMed, bets against scepticsafr.com - January 23 at 2:56 AMResMed says its masks to remain on market despite FDA classificationreuters.com - January 16 at 1:02 PM Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address $5,000 Gold? (Ad)Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now). Find out how to do right here in this free video. RMD Media Mentions By Week RMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RMD News Sentiment▼1.250.32▲Average Medical News Sentiment RMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RMD Articles This Week▼72▲RMD Articles Average Week Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ansell News Today Carl Zeiss Meditec News Today Coloplast A/S News Today ConvaTec Group News Today Fielmann Group News Today Fisher & Paykel Healthcare News Today Gerresheimer News Today InnerScope Hearing Technologies News Today Innovative Eyewear News Today Nanosonics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:RMD) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
